A Study of Plasma miR-23a Expression in Vitiligo Patients

Assessment of C-X-C Motif Chemokine Ligand 10 (CXCL10) Serum Level in Patients with Vitiligo

Immunohistochemical Expression of Mortalin in Vitiligo Patients

Interleukin-36α Expression in Vitiligo Skin Lesions and Its Association with Disease Pattern, Activity, and Severity

Assessment of Serum MicroRNA-221-3p and Tumor Necrosis Factor-α Levels in Patients with Chronic Plaque Psoriasis: A case-control Study

Assessment of Awareness and Psychological Status of Vitiligo Patients in Selected Dermatological Hospitals at Minia City

Study Of Microrna 22 Level in Psoriasis Patients”

Assessment of 8-Hydroxy-2-Deoxyguanosine in Vitiligo Patients

Current insight into the roles of microRNA 25-5p and microphthalmia-associated transcription factor in the pathogenesis of non-segmental vitiligo

MicroRNA 196a-2 Polymorphism and Serum Tyrosinase Level in Vitiligo Patients